AMANDA COLEMAN: Open Payments
NPI 1649864414 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,979 in 92 payments from 24 companies in 2025. Trend: 2023 $1,634 · 2024 $1,735 · 2025 $1,979
Food & beverage: $1,483Consulting: $350Education: $146
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $413 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $254 |
| JAZZ PHARMACEUTICALS INC. | 7 | $238 |
| Teva Pharmaceuticals USA, Inc. | 6 | $157 |
| Inspire Medical Systems, Inc. | 9 | $154 |
| HARMONY BIOSCIENCES LLC | 4 | $101 |
| Neurocrine BioSciences, Inc. | 4 | $84 |
| Celgene Corporation | 4 | $69 |
| Genentech USA, Inc. | 3 | $67 |
| SK Life Science, Inc. | 2 | $51 |
Products named: QULIPTA, LUMRYZ, XYWAV, INSPIRE, UBRELVY, INGREZZA, ZEPOSIA, AUSTEDO XR.
Industry payments across ID — which companies pay providers there.
